EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta‐analysis

Pedro Henrique Siedschlag Schmidt iD, Vitor Sodré Nonato de Souza iD, Luís Guilherme Machado iD, João Vitor Ahlf Rodrigues iD, João Victor Ramos da Cruz iD, Lis Sodré Nonato de Souza iD, Bruno Eulálio Dos Santos iD, Alexandre Hohl iD, Marcelo Fernando Ronsoni iD, Simone van de Sande-Lee iD

Diabetes, Obesity and Metabolism · 2026-04 · 28 (4) · 3335-3343

DOI: 10.1111/dom.70529 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 18.02.2026. Verfasst von Pedro Henrique Siedschlag Schmidt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil. Hauptthemen laut MEDLINE: Tirzepatide, Obesity, Overweight. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the effects of tirzepatide on physical function in adults with overweight or obesity.

Methods

We searched PubMed, Embase, and the Cochrane Library up to July 20, 2025 for randomized controlled trials (RCTs) comparing once‐weekly tirzepatide 10 or 15 mg with placebo and reporting validated physical function outcomes. Primary endpoints were changes from baseline in the 36‐Item Short Form Health Survey (SF‐36) physical function domain and in the Impact of Weight on Quality of Life‐Lite Clinical Trials (IWQOL‐Lite‐CT) physical function subscale. Random‐effects models were used to calculate pooled mean differences (MD) with 95% confidence intervals (CI). Heterogeneity was assessed with I 2 statistics.

Results

Six RCTs comprising 4531 participants, of whom 2802 underwent tirzepatide treatment were included. Tirzepatide significantly improved physical function compared with placebo, both in SF‐36 physical function (MD 2.26 points; 95% CI, 1.76–2.76; I 2 = 99.8%; p < 0.001) and IWQOL‐Lite‐CT physical function (MD 10.10 points; 95% CI, 8.61–11.60; I 2 = 99.8%; p < 0.001). Subgroup analyses by dose demonstrated consistent benefits for both 10 and 15 mg groups. The overall certainty of evidence, rated by GRADE, was moderate due to risk of bias and inconsistency across studies.

Conclusions

Tirzepatide 10 and 15 mg once weekly significantly improve patient‐reported physical function in adults with overweight or obesity. These findings suggest tirzepatide enhances perceived physical capacity and quality of life, although the extremely high between‐study heterogeneity limits the interpretability of pooled estimates and warrants cautious interpretation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatideObesityOverweightHumansQuality of LifeRandomized Controlled Trials as TopicAdultAnti-Obesity AgentsTreatment Outcome

Stichwörter der Autor:innen

GIPGLP‐1 analoguemeta‐analysispatient reported outcomessystematic review

Substanzen

TirzepatideAnti-Obesity Agents

Autor:innen und Institutionen

  • Department of Medicine, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
  • Department of Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil.

ORCID-Profile: Pedro Henrique Siedschlag Schmidt, Vitor Sodré Nonato de Souza, Luís Guilherme Machado, João Vitor Ahlf Rodrigues, João Victor Ramos da Cruz, Lis Sodré Nonato de Souza, Bruno Eulálio Dos Santos, Alexandre Hohl, Marcelo Fernando Ronsoni, Simone van de Sande-Lee

Zitieren

APA

Schmidt, P. H. S., de Souza, V. S. N., Machado, L. G., Rodrigues, J. V. A., da Cruz, J. V. R., de Souza, L. S. N., Dos Santos, B. E., Hohl, A., Ronsoni, M. F., & van de Sande-Lee, S. (2026). Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism, 28(4), 3335-3343. https://doi.org/10.1111/dom.70529

Vancouver

Schmidt PHS, de Souza VSN, Machado LG, Rodrigues JVA, da Cruz JVR, de Souza LSN, et al. Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism. 2026;28(4):3335-3343. doi:10.1111/dom.70529

BibTeX
@article{Schmidt2026,
  author = {Schmidt, Pedro Henrique Siedschlag and de Souza, Vitor Sodré Nonato and Machado, Luís Guilherme and Rodrigues, João Vitor Ahlf and da Cruz, João Victor Ramos and de Souza, Lis Sodré Nonato and Dos Santos, Bruno Eulálio and Hohl, Alexandre and Ronsoni, Marcelo Fernando and van de Sande-Lee, Simone},
  title = {Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta‐analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {3335--3343},
  doi = {10.1111/dom.70529}
}
Kostenlos starten →